Skip To Main Content
Yingmiao Liu on Muck Rack

Yingmiao Liu

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingmiao

Contact Yingmiao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patients

|
By Andrew Nixon Verified, Fabio Navarro, Katherine Zhou, Charles Abbott, Lee McDaniel, Lauren Howard, J. Brady, Donna Niedzwiecki, John Strickler, Sean Boyle, Richard Chen, Hope E. Uronis, Neeraja Ravi, Yingmiao Liu, Jingquan Jia
| Nature Verified
Abstract To explore whether ultra-sensitive circulating tumor DNA (ctDNA) profiling enables earlier prediction of treatment response and detection of disease progression, we applied NeXT Personal, an ultra-sensitive bespoke tumor-informed liquid biopsy platform, to profile tumor samples from the KeyLargo study, a phase II trial in which metastatic esophagogastric cancer (mEGC) patients received capecitabine, oxaliplatin, and pembrolizumab.
Open in Who Shared Issue with article?
See all 1 articles